Expression, regulation and function of microRNAs in multiple sclerosis.

Area of Science:

• Molecular Biology
• Genetics
• Neuroimmunology

Background:

• MicroRNAs (miRNAs) are crucial regulators of post-transcriptional gene silencing.
• Aberrant miRNA expression is increasingly recognized in the pathogenesis of multiple sclerosis (MS).

Purpose of the Study:

• To investigate the role of dysregulated microRNAs (miRNAs) in multiple sclerosis (MS).
• To identify potential miRNA-based biomarkers and therapeutic targets for MS.

Main Methods:

• Analysis of miRNA expression profiles in peripheral blood mononuclear cells (PBMCs), plasma, and brain tissues from MS patients and mouse models.
• Comparison of miRNA levels between MS patients and healthy controls.
• Review of existing literature on miRNA involvement in MS pathogenesis and treatment.

Main Results:

• Several miRNAs, including miR-21, miR-142-3p, miR-146a, miR-146b, miR-155, and miR-326, were found to be upregulated in MS patients and models.
• Other miRNAs, such as miR-15a, miR-19a, miR-22, miR-210, and miR-223, were also upregulated in regulatory T cells (Tregs) and other MS-related samples.
• Conversely, miR-15a, miR-15b, miR-181c, and miR-328 were downregulated in MS.
• MS treatments like interferon-β and glatiramer acetate may modulate miRNA expression.

Conclusions:

• Dysregulated miRNAs are implicated in MS pathogenesis and could serve as diagnostic signatures.
• Specific miRNAs, such as miR-155 and miR-326, represent promising therapeutic targets and diagnostic markers for MS.